Top Private Label OTC Pharmaceutical Manufacturers

Introduction

Retailers, supplement companies, and emerging health brands struggle when off-the-shelf OTC inventory limits brand control. They need formulas built around their brand, pricing they set, and a manufacturer who can scale with them.

That demand is why private-label OTC manufacturing matters now. U.S. retail sales of OTC medicines and related health products reached $58.2 billion in 2025, according to the Consumer Healthcare Products Association. Store brands are fighting for a bigger piece of that shelf space.

This guide covers manufacturers that build private-label OTC products end to end—development, production, packaging, and regulatory execution—not companies that only sell finished brands. We'll compare regulatory readiness, dosage-form range, quality systems, and buyer fit so you know what to ask before signing a contract.

Key Takeaways

• Private-label OTC drugs are made by one company and sold under another’s brand, with split roles for manufacturer, brand owner, and retailer.
• FDA registration, cGMP compliance, and compliant Drug Facts labeling need to be verified together, not assumed from a single credential.
• Choose a manufacturer based on product category, dosage form, batch size, and sales channel.
• Homeocare offers private-label and contract manufacturing for homeopathic OTC remedies—not conventional monograph OTC drugs.
• Always confirm current certifications, quality agreements, and commercial terms directly with any manufacturer before committing.

Overview of Private-Label OTC Pharmaceutical Manufacturing in the U.S. Market

Private-label OTC pharmaceuticals are nonprescription drug products manufactured for a retailer or brand owner and sold under that company's name instead of the manufacturer's. That's different from:

• Generic prescription drugs — compared against a reference drug through an FDA-reviewed ANDA, a separate pathway from OTC.
• National-brand OTC products — sold under the manufacturer's own trademark.
• Dietary supplements — intended to supplement the diet, not to treat, diagnose, cure, or prevent disease.
• Homeopathic OTC products — a distinct FDA category discussed below.

How the Supply Chain Actually Works

A private-label OTC product typically moves through several stages before it reaches a shelf:

1. Concept and formulation — the brand owner or manufacturer defines the product and its intended use.
2. Ingredient sourcing — active ingredients and excipients are procured and verified.
3. Manufacturing and testing — production runs under cGMP controls with batch-specific quality checks.
4. Packaging and labeling — includes compliant Drug Facts panels and brand-specific artwork.
5. Batch release and distribution — product ships only after quality release.
6. Post-market responsibilities — includes complaint handling and, where applicable, adverse event reporting.

Why Brands Choose Private-Label Manufacturers

Building an in-house production line is expensive and slow. An established manufacturer gives brands:

• Faster market entry without building a facility from scratch
• Access to formulation and regulatory expertise already in place
• Flexibility across dosage forms (tablets, liquids, topicals) without new tooling
• Retailer-specific SKUs at competitive cost

A Critical Regulatory Distinction

Conventional OTC drugs are marketed under an FDA monograph or an approved drug application. Homeopathic OTC products follow a separate track entirely: the FDA states plainly that no homeopathic product is FDA-approved, and the agency's 2022 enforcement guidance treats homeopathic drugs differently from the monograph system.

Treating these two categories as interchangeable is a mistake that shows up in buyer due diligence too often.

With that distinction in mind, the manufacturers below should be judged on documented capability and fit for your product, not on size or name recognition.

Top Private-Label OTC Pharmaceutical Manufacturers in the U.S.

Each entry was scored against the same bar:

• Verified private-label or contract-manufacturing relevance
• U.S. service capability
• Regulatory and quality infrastructure
• Dosage-form range, category expertise, and buyer-scale fit

Homeocare

Homeocare has operated since 1995 in natural homeopathic remedies and related consumer health products. Formulations draw from European homeopathic masters, with turnkey programs for supplement companies and private-label brands—including higher-volume runs.

Core services include:

• Wholesale fulfillment
• Private-label manufacturing
• Contract manufacturing
• Contract packaging

Homeocare identifies as an FDA-registered homeopathic OTC drug establishment and describes itself as cGMP-compliant, with quality control maintained throughout production. Registration means the facility is listed with FDA. It does not mean the agency approved a specific formula or claim, so brand owners still need product-specific labeling and claims support.

Documented manufacturing and packaging formats include:

• Tablets and pellets
• Capsules
• Creams, ointments, and gels
• Liquids

Its private-label intake asks for sales channel and expected quantity per product, which points to flexibility across order sizes. Confirm current MOQs and lead times directly.

Perrigo

Perrigo operates at the scale most private-label OTC buyers link to major retail programs. In its February 2026 earnings release, the company reported U.S. store brands gained 60 basis points of volume share in fiscal 2025 and 120 basis points in the fourth quarter.

That gain is Perrigo’s own business result, not a market-wide private-label figure. It still signals active store-brand OTC manufacturing.

Perrigo's corporate materials describe companywide liquid, solid, and semi-solid manufacturing across categories including upper respiratory, digestive health, pain relief, and sleep aids. A documented 2016 launch, a store-brand guaifenesin/dextromethorphan extended-release tablet built for retail and wholesale customers, illustrates the kind of national-brand-equivalent product Perrigo has historically supported.

What's not publicly verified is a plant-by-plant breakdown of which U.S. facilities handle which dosage forms, so brands should request site-specific documentation rather than assume companywide capability applies everywhere.

PL Developments

PL Developments manufactures, packages, and distributes private-label liquid- and solid-dose OTC pharmaceuticals, including first-aid products, for retail and wholesale customers. Its manufacturing operations cover tablet compression and coating along with liquid compounding and filling.

The company says its facilities are built to meet cGMP standards and calls the operation "FDA-compliant." Treat that as a company claim, not an independent certification, and request the supporting documentation.

Buyers considering PL Developments should note:

• Published capacity figures are undated—use them as directional only
• Named retailer or wholesale customers were not independently verified in current materials
• Liquid- and solid-dose focus makes it a stronger fit for brands in those formats

LNK International

LNK International says solid- and liquid-dose OTC pharmaceuticals are its only business. Based on Long Island, New York, it produces pain-relief, cough-and-cold, and gastrointestinal products. Customers typically include drug chains, supermarkets, and mass retailers building store brands.

LNK states production follows federal cGMP standards with documented, validated processes. For due diligence: FDA issued a warning letter in September 2019 citing cGMP violations at the Hauppauge facility after inspection. That finding is historical, not proof of current status, but buyers should ask the manufacturer to address it before contracting.

This kind of specialization can cut both ways:

• A focused manufacturer may offer deeper category expertise in its core dosage forms
• It may offer less flexibility outside those formats compared to a diversified CDMO

Aphena Pharma Solutions

Aytu BioPharma’s current materials focus on specialty CNS therapeutics, and no active private-label or contract OTC service under “DivisionM” could be verified. Aphena Pharma Solutions is included instead as a documented, active U.S. OTC contract manufacturer and packager.

Aphena’s Easton, Maryland facility handles liquids and topicals manufacturing and packaging. Its Cookeville, Tennessee site handles solid-dose packaging—not solid-dose manufacturing—so confirm in-house tablet production before you assume it.

Documented formats include liquids, gels, creams, ointments, foams, suspensions, and lotions.

Aphena describes both sites as FDA-registered and cGMP-compliant and says it runs small orders through multi-thousand-unit batches. Those claims are undated company statements—request current registration numbers and a recent audit summary before finalizing a program.

How We Chose the Best Private-Label OTC Pharmaceutical Manufacturers

Rankings here reflect documented capability and buyer fit, not unverified claims about being the largest, cheapest, or most reliable option. Four areas mattered most.

Regulatory readiness

• FDA establishment registration where applicable
• cGMP compliance and documented quality agreements
• Batch records, deviation procedures, and recall processes
• Stability data and product-specific testing documentation

Manufacturing fit

• Active ingredient and dosage-form capability
• Equipment and packaging format availability
• Minimum order quantities, batch sizes, and lead times
• Ability to support formula or format changes over time

Commercial and operational support

• Product development and analytical testing
• Drug Facts label review and compliance
• Sourcing, inventory planning, and fulfillment support
• Responsiveness during commercialization

Product-market fit

• Therapeutic category expertise
• Clear distinction between homeopathic and conventional OTC scope
• Retail or e-commerce channel requirements
• Alignment with intended consumer claims

Capability checks only go so far. These mistakes still derail private-label deals.

Common Selection Mistakes to Avoid

1. Choosing on price alone. The lowest quote often hides gaps in testing or documentation.
2. Confusing registration with approval. FDA is clear that establishment registration and drug listing do not mean products are approved, or that the agency verified the submitted information.
3. Skipping labeling ownership. Someone needs to be accountable for Drug Facts compliance, and it should be spelled out in writing.
4. Ignoring supply continuity. Ask how the manufacturer handles ingredient shortages or facility disruptions before you need the answer.

Before signing anything, request a due-diligence package that covers:

• Current certifications
• Facility and product scope
• Sample quality documentation
• References where available
• Commercial terms
• What the manufacturer performs directly versus through partners

Conclusion

No single private-label OTC manufacturer fits every brand. The right partner is the one whose regulatory scope, dosage-form capabilities, quality systems, and production scale match what you need right now.

Compare manufacturers on documented evidence:

• Product-specific compliance review
• Testing and labeling responsibilities
• Minimum volumes and lead times
• Packaging capacity

Reputation alone won't catch a gap in your quality agreement.

If you're a supplement company or private-label brand exploring homeopathic OTC manufacturing, contract manufacturing, or contract packaging, Homeocare can walk through formulations, formats, and project requirements. Its documented scope centers on homeopathic and natural-remedy products rather than every conventional OTC category.

Frequently Asked Questions

What are private-label drugs?

Private-label drugs are manufactured by one company and sold under another company's brand name, typically a retailer or brand owner. The brand owner handles marketing and sales, while the manufacturer manages production, testing, and regulatory documentation.

What are the labeling requirements for over-the-counter drugs?

FDA requires a standardized Drug Facts label covering active ingredients, purpose, uses, warnings, directions, and inactive ingredients. Manufacturer or distributor details must also appear, and labeling needs product-specific regulatory review before launch.

How do I choose a private-label OTC drug manufacturer?

Check regulatory credentials, cGMP systems, and dosage-form experience in your specific category. Then confirm testing documentation, minimum order quantities, lead times, packaging options, and how well the manufacturer scales as your volume grows.

Is an FDA-registered OTC manufacturer the same as an FDA-approved manufacturer?

No. Establishment registration means a facility is listed with FDA, not that the agency has approved every product, claim, or formulation made there. Always verify which regulatory pathway applies to your specific product.

Can homeopathic products be manufactured as private-label OTC products?

Yes, some manufacturers, including Homeocare, support homeopathic OTC private-label production. Buyers still need to confirm the manufacturer's documented scope, applicable FDA requirements, formulation details, and labeling claims before moving forward.

Are private-label OTC medicines the same quality as national-brand medicines?

Quality depends on formulation, ingredients, manufacturing controls, testing, and regulatory compliance, not the name on the box. Review actual documentation and quality evidence rather than assuming equivalence based on branding alone.